# OnCo record paper-quantum-first-quizartinib-lancet-2023 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-quantum-first-quizartinib-lancet-2023/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-quantum-first-quizartinib-lancet-2023" ;
  schema:name "QuANTUM-First: quizartinib added to intensive chemotherapy and continued as maintenance in newly diagnosed FLT3-ITD AML"@en ;
  schema:description "Adding the FLT3 inhibitor quizartinib to standard chemotherapy, and continuing it for up to three years, roughly doubled median survival in FLT3-ITD acute myeloid leukaemia."@en ;
  schema:url <https://onco.cc/key-papers/paper-quantum-first-quizartinib-lancet-2023/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=QuANTUM-First%20quizartinib%20FLT3-ITD%20Erba%20Lancet%202023>, <https://clinicaltrials.gov/study/NCT02668653> ;
  schema:sameAs <https://doi.org/10.1016/S0140-6736(23)00464-6> ;
  schema:datePublished "2023"^^xsd:gYear ;
  schema:author "Erba HP, Montesinos P, Kim HJ, et al." ;
  onco:related <https://onco.cc/pairings/flt3i-plus-7-3/>, <https://onco.cc/key-papers/paper-admiral-gilteritinib-flt3-nejm-2019/> ;
  onco:cancers <https://onco.cc/cancers/aml/> ;
  onco:technologies <https://onco.cc/technologies/allogeneic-hsct/> ;
  onco:targets <https://onco.cc/targets/flt3/> ;
  onco:drugs <https://onco.cc/drugs/quizartinib/>, <https://onco.cc/drugs/midostaurin/>, <https://onco.cc/drugs/gilteritinib/>, <https://onco.cc/drugs/cytarabine-7-3/> ;
  onco:companies <https://onco.cc/companies/daiichi-sankyo/> ;
  onco:terms <https://onco.cc/terms/os/> ;
  onco:trials <https://onco.cc/trials/quantum-first/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-resistance/>, <https://onco.cc/bottlenecks/b-dose-optimisation/> ;
  onco:journals <https://onco.cc/journals/lancet/> .